GE Capital, Healthcare Financial Services, an operating unit of General Electric Company (GE), recently served as the administrative agent and sole lender for a $7.5 million-worth senior secured credit facility for OraMetrix, Inc. The debt financing will augment OraMetrix’s liquidity and working capital requirements to fuel further growth.
Revolutionizing orthodontic care, OraMetrix offers pioneering 3-D technology solutions to provide patients with the most precise and high-quality treatment available in the industry. The SureSmile system, a proprietary technology of the company, equips doctors with increased precision and control to facilitate an effortless maneuver for shorter treatment times, less overall discomfort and fewer office visits for patients.
OraMetrix is likely to utilize the credit facility to increase its financial flexibility and support its capital expenditures to remain competitive in the industry with continuous research and development initiatives.
General Electric is one of the largest and the most diversified technology and financial services corporations in the world. With products and services ranging from aircraft engines, power generation, water processing, and security technology to medical imaging, business and consumer financing, media content, and industrial products, the company serves over 100 million customers worldwide.
Its segments include Power & Water, Oil & Gas, Energy Management, Aviation, Healthcare, Transportation, Home & Business Solutions, and GE Capital. With more than $60 billion debt financing transactions in the last 10 years across 45 healthcare sectors, GE Capital, Healthcare Financial Services has an in-depth industry know-how and expertise as a reliable debt provider.
General Electric currently has a Zacks Rank #3 (Hold). Other companies in the industry that are worth mentioning include Compass Diversified Holdings (CODI), ITT Corporation (ITT) and Honeywell International Inc. (HON), each carrying a Zacks Rank #2 (Buy).
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment